Orion (OEC)
NYSE Market Open
Orion S.A. is a global producer of carbon black, a finely divided form of carbon used to change the strength, durability, conductivity, colour, and processing characteristics of industrial materials. The company supplies customers across automotive, tire, coatings, plastics, printing, battery, and other specialty markets, making it part of the chemical supply chain behind many everyday and industrial products.
Orion reports its business through two main segments: Rubber Carbon Black and Specialty Carbon Black. Rubber Carbon Black is the larger revenue contributor and is primarily used to reinforce tires and mechanical rubber goods, where it helps improve wear resistance, tensile strength, and overall performance. Demand in this segment is closely tied to tire production, vehicle use, replacement tire cycles, and broader industrial activity.
The Specialty Carbon Black segment serves higher-value applications where carbon black functions as a pigment or performance additive. These products are used in coatings, inks, polymers, cables, conductive compounds, and other applications that require specific colour, electrical, or technical properties. Specialty grades can be more customized than standard rubber grades, giving Orion exposure to markets where material performance is a key purchasing factor.
The company operates internationally, with a significant revenue base in Europe and particularly Germany, according to its reported geographic mix. Orion’s position is shaped by manufacturing scale, technical know-how, customer qualification requirements, and the need to meet environmental and quality standards in a heavily regulated chemicals industry.
Last updated
- Market Cap
- 410.51M
- P/E
- —
- P/FCF
- 11.7
- P/S
- 0.23
- Enterprise Value
- 1.37B
- Sector
- —
- Industry
- —
- Address
- 1700 CITY PLAZA DRIVE, SUITE 300, SPRING, TX, 77389
Orion-konsernin osavuosikatsaus tammi–maaliskuu 2026
Gabelli Hosts 17th Annual Specialty Chemicals Symposium
Orion Group Interim Report January–September 2025
Orion-konsernin osavuosikatsaus tammi–syyskuu 2025
Orion-konsernin puolivuosikatsaus tammi–kesäkuu 2025
Sisäpiiritieto: Orion parantaa näkymäarviota vuodelle 2025
Orion ja Glykos laajentavat tutkimusyhteistyö- ja lisenssisopimustaan seuraavan sukupolven vasta-ainekonjugaattien kehittämiseksi
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
Orionin yhteistyökumppani MSD laajentaa opevesostaatin kliinistä kehitysohjelmaa naisten syöpiin
Orion-konsernin osavuosikatsaus tammi–maaliskuu 2025
Lääketeollisuus luovutti hallitukselle arvolupauksen: miljarditason investoinnit vuoteen 2030 mennessä
Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide
Orionin yhteistyökumppani Bayer hakee Kiinassa kolmatta indikaatiota darolutamidille
Orion ja Abilita Therapeutics sopivat tutkimusyhteistyöstä ja lisenssisopimusoptiosta innovatiivisten vasta-ainehoitojen kehittämiseksi
Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics
Sisäpiiritieto: Orion lopettaa ODM-111-kehitysohjelman perustuen molekyylin liian kapeaan terapeuttiseen ikkunaan
Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule
Orionin yhteistyökumppani Bayer hakee EU:ssa kolmatta indikaatiota darolutamidille
Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU
Darolutamidi yhdessä ADT-hoidon kanssa pienensi merkitsevästi (46 prosentilla) syövän etenemisen tai kuoleman riskiä verrattuna lumelääkkeen ja ADT:n yhdistelmään levinnyttä hormonisensitiivistä eturauhassyöpää sairastavilla potilailla
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 410.51M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 1.37B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.08
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.23
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 6.49
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.77
- EPS
- -1.58
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 1.14%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 11.7
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 2.02
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 35.1M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -23.48%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -4.61%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 2.67
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.62
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.08
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 460.37K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 7.28
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 459.5M | 411.7M | 450.9M | 466.4M | 477.7M |
| Gross profit | 79.2M | 77.7M | 85.6M | 98.4M | 98.1M |
| Operating income | 11.4M | 13.5M | -52.3M | 32.1M | 31.2M |
| EBITDA | 44.1M | 41.3M | 62.2M | 64.1M | 62.7M |
| Net income | -9.9M | -21.1M | -67.1M | 9M | 9.1M |
| Basic EPS | -0.18 | -0.37 | -1.2 | 0.16 | 0.16 |
| Diluted EPS | -0.18 | -0.37 | -1.2 | 0.16 | 0.16 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 1.93B | 1.91B | 1.96B | 2.02B | 1.97B |
| Total liabilities | 1.55B | 1.52B | 1.56B | 1.56B | 1.5B |
| Total equity | 379.5M | 384.6M | 401.8M | 466.5M | 466.1M |
| Cash & equivalents | 50.5M | 60.7M | 51.3M | 42.6M | 37.5M |
| Current assets | 661.5M | 643.8M | 683.5M | 682.5M | 688.6M |
| Current liabilities | 659.7M | 626.4M | 635.3M | 620.8M | 601.9M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -12.4M | 92.9M | 68.8M | 53.7M | 400K |
| Investing cash flow | -36.1M | -48.7M | -40.9M | -42.2M | -29.2M |
| Financing cash flow | 39.6M | -35.7M | -19.5M | -7.8M | 21.8M |
| Change in cash | -8.9M | 8.5M | 8.4M | 3.7M | -7M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Orion S.A. | View Filing | |
| edgar index | 10-Q — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| form 4 | Form 4 — Niewiem Sandra | View Filing | |
| form 4 | Form 4 — Painter Corning F. | View Filing | |
| form 4 | Form 4 — Puckett Jonathan A. | View Filing | |
| form 4 | Form 4 — Quinones Carlos | View Filing | |
| form 4 | Form 4 — Riveros Pedro | View Filing | |
| edgar index | ARS — Orion S.A. | View Filing | |
| edgar index | DEF 14A — Orion S.A. | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | PRE 14A — Orion S.A. | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| edgar index | SCHEDULE 13G — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| form 4 | Form 4 — Niewiem Sandra | View Filing | |
| form 4 | Form 4 — Niewiem Sandra | View Filing | |
| form 4 | Form 4 — Niewiem Sandra | View Filing | |
| form 4 | Form 4 — Painter Corning F. | View Filing | |
| form 4 | Form 4 — Painter Corning F. | View Filing | |
| form 4 | Form 4 — Painter Corning F. | View Filing | |
| form 4 | Form 4 — Quinones Carlos | View Filing | |
| form 4 | Form 4 — Quinones Carlos | View Filing | |
| form 4 | Form 4 — Quinones Carlos | View Filing | |
| form 4 | Form 4 — Riveros Pedro | View Filing | |
| form 4 | Form 4 — Riveros Pedro | View Filing | |
| form 4 | Form 4 — Riveros Pedro | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| edgar index | 10-K — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| form 4 | Form 4 — Puckett Jonathan A. | View Filing | |
| edgar index | 3 — Orion S.A. | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| edgar index | 10-Q — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| edgar index | 10-Q — Orion S.A. | View Filing | |
| edgar index | SCHEDULE 13G/A — Orion S.A. | View Filing | |
| edgar index | 8-K — Orion S.A. | View Filing | |
| edgar index | SCHEDULE 13G/A — Orion S.A. | View Filing | |
| edgar index | 3 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| edgar index | 4 — Orion S.A. | View Filing | |
| form 4 | Form 4 — GALVIN KERRY A | View Filing |